Caris Life Sciences

IRVING, Texas, May 15, 2026 Caris Life Sciences announced the publication of a new study in The Oncologist demonstrating...

IRVING, Texas, May 11, 2026 Caris Life Sciences announced the publication of a new study in Cancer Immunology, Immunotherapy...

IRVING, Texas, May 8, 2026 Caris Life Sciences® has submitted an application to the New York State Department of...

IRVING, Texas – May 4, 2026 Caris Life Sciences has secured MolDX approval for its flagship Caris ChromoSeq™ assay,...

IRVING, Texas, USA — April 1, 2026 Caris Life Sciences® has announced the launch of Caris ChromoSeq™, the world’s...

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

IRVING, Texas, USA, March 31, 2026 Caris Life Sciences has announced final results from the Achieve 1 study, demonstrating...

IRVING, Texas, February 26, 2026 Caris Life Sciences® (NASDAQ: CAI) announced an interim readout from its Achieve 1 clinical...